Seeking Alpha

MAPP
  MAP Pharmaceuticals, Inc. - NASDAQ

11/26/2014, 12:47 PM ET
  • Hedge Fund Live | Send Message 9 May 2011

    MAPP buying heavy vol on breakout
    Reply
      Company Description
      MAP Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new therapies to address undermet patient needs in neurology. The Company is developing LEVADEX®, an orally inhaled investigational drug for the potential acute treatment of migraine. The U.S. Food and... More